Incisive Genetics
Vancouver, CA · 1 known investors
Find your way into Incisive Genetics
Incisive Genetics develops non-viral gene editing therapeutics using proprietary lipid nanoparticle delivery technology to treat genetic diseases by editing genes directly in target tissues. The company focuses initially on Huntington's disease and is advancing toward human clinical trials.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeedJul 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Incisive Genetics do?
- Incisive Genetics develops non-viral gene editing therapeutics using proprietary lipid nanoparticle delivery technology to treat genetic diseases by editing genes directly in target tissues. The company focuses initially on Huntington's disease and is advancing toward human clinical trials.
- Who are Incisive Genetics's investors?
- Incisive Genetics's investors include Saltagen Ventures.
- Where is Incisive Genetics headquartered?
- Incisive Genetics is headquartered in Vancouver, CA.
